Elisabetta Fenocchio

2.1k total citations
29 papers, 337 citations indexed

About

Elisabetta Fenocchio is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elisabetta Fenocchio has authored 29 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 9 papers in Pathology and Forensic Medicine and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elisabetta Fenocchio's work include Colorectal Cancer Treatments and Studies (19 papers), Genetic factors in colorectal cancer (7 papers) and Cancer Treatment and Pharmacology (5 papers). Elisabetta Fenocchio is often cited by papers focused on Colorectal Cancer Treatments and Studies (19 papers), Genetic factors in colorectal cancer (7 papers) and Cancer Treatment and Pharmacology (5 papers). Elisabetta Fenocchio collaborates with scholars based in Italy, Spain and United States. Elisabetta Fenocchio's co-authors include Massimo Aglietta, Francesco Leone, Sara Lonardi, Pasquale Lombardi, Filippo Pietrantonio, Salvatore Siena, Anna Sapino, Andrea Sartore‐Bianchi, Alberto Bardelli and Silvia Marsoni and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Elisabetta Fenocchio

28 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elisabetta Fenocchio Italy	12	242	99	87	83	73	29	337
Aurélie Ferru France	11	250 1.0×	86 0.9×	82 0.9×	84 1.0×	39 0.5×	30	439
Jamil Asselah Canada	11	224 0.9×	88 0.9×	120 1.4×	28 0.3×	116 1.6×	29	373
Hiromichi Shirasu Japan	10	232 1.0×	143 1.4×	168 1.9×	119 1.4×	96 1.3×	32	395
Sofía del Carmen Spain	9	121 0.5×	86 0.9×	55 0.6×	49 0.6×	60 0.8×	23	248
Megan Greally Ireland	9	231 1.0×	49 0.5×	161 1.9×	68 0.8×	121 1.7×	41	399
Sabina Murgioni Italy	11	214 0.9×	76 0.8×	145 1.7×	105 1.3×	85 1.2×	38	361
Nicolas Sommer United States	11	260 1.1×	70 0.7×	107 1.2×	107 1.3×	42 0.6×	27	356
Çağlayan Geredeli Türkiye	10	210 0.9×	73 0.7×	108 1.2×	37 0.4×	61 0.8×	49	304
Nikoletta Sidiropoulos United States	8	163 0.7×	135 1.4×	114 1.3×	33 0.4×	50 0.7×	21	336
Valentina Tateo Italy	10	205 0.8×	96 1.0×	150 1.7×	34 0.4×	106 1.5×	36	437

Countries citing papers authored by Elisabetta Fenocchio

Since Specialization

Citations

This map shows the geographic impact of Elisabetta Fenocchio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Fenocchio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Fenocchio more than expected).

Fields of papers citing papers by Elisabetta Fenocchio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Fenocchio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Fenocchio. The network helps show where Elisabetta Fenocchio may publish in the future.

Co-authorship network of co-authors of Elisabetta Fenocchio

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Fenocchio. A scholar is included among the top collaborators of Elisabetta Fenocchio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Fenocchio. Elisabetta Fenocchio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Migliore, Cristina, Elisabetta Fenocchio, Silvia Giordano, & Simona Corso. (2025). Precision oncology in gastric cancer: Shaping the future of personalized treatment. Cancer Treatment Reviews. 141. 103038–103038.

Bellomo, Sara E., Enrico Berrino, Simona Bo, et al.. (2025). Clinical significance of preoperative nutrition and inflammation assessment tools in gastrointestinal cancer patients undergoing surgery: a retrospective cohort study. Frontiers in Nutrition. 12. 1551048–1551048. 1 indexed citations

Germani, Marco Maria, Rossana Intini, Maria Bensi, et al.. (2024). Treatment of patients with BRAF-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset. ESMO Open. 9(4). 102996–102996. 4 indexed citations

Rizzo, Alessio, Manuela Racca, Elisabetta Fenocchio, et al.. (2023). Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 24(12). 10136–10136. 10 indexed citations

Barretta, Francesco, Francesca Corti, Sara Lonardi, et al.. (2023). Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer. Journal for ImmunoTherapy of Cancer. 11(1). e005493–e005493. 13 indexed citations

Berrino, Enrico, Emanuele Valtorta, Vito Amodio, et al.. (2023). Unique Patterns of Heterogeneous Mismatch Repair Protein Expression in Colorectal Cancer Unveil Different Degrees of Tumor Mutational Burden and Distinct Tumor Microenvironment Features. Modern Pathology. 36(2). 100012–100012. 15 indexed citations

Cohen, Romain, Sara Lonardi, Francesca Corti, et al.. (2022). Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer. European Journal of Cancer. 172. 171–181. 11 indexed citations

Berrino, Enrico, Roberto Filippi, Elisabetta Fenocchio, et al.. (2022). Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors. npj Precision Oncology. 6(1). 15–15. 12 indexed citations

Corti, Francesca, Sara Lonardi, Rossana Intini, et al.. (2021). The Pan-Immune-Inflammation Value in microsatellite instability–high metastatic colorectal cancer patients treated with immune checkpoint inhibitors. European Journal of Cancer. 150. 155–167. 78 indexed citations

10.

Sartore‐Bianchi, Andrea, Filippo Pietrantonio, Sara Lonardi, et al.. (2021). Phase II study of anti-EGFR rechallenge therapy with panitumumab driven by circulating tumor DNA molecular selection in metastatic colorectal cancer: The CHRONOS trial.. Journal of Clinical Oncology. 39(15_suppl). 3506–3506. 47 indexed citations

11.

Sartore‐Bianchi, Andrea, Federica Tosi, Francesca Bergamo, et al.. (2020). 507P Central nervous system recurrence in HER2-positive metastatic colorectal cancer. Annals of Oncology. 31. S455–S455. 2 indexed citations

12.

Lombardi, Pasquale, Roberto Filippi, R Ferraris, et al.. (2020). 448P Predictive factor of cardiotoxicity in fluoropyrimidine-treated colorectal cancer patients: Interim analysis of the prospective observational CHECKPOINT trial. Annals of Oncology. 31. S432–S432. 1 indexed citations

13.

Rizzo, Alessandro, Simona Tavolari, Angela Dalia Ricci, et al.. (2020). Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and Failures. Cancers. 12(11). 3256–3256. 8 indexed citations

14.

Lombardi, Pasquale, Ilaria Depetris, Alessandro Bonzano, et al.. (2019). Fluoropyrimidine-induced cardiotoxicity in colorectal cancer patients: Preliminary data from the prospective observational CHECKPOINT trial (NCT02665312). Annals of Oncology. 30. v222–v223. 1 indexed citations

15.

Fenocchio, Elisabetta, Roberto Filippi, Ilaria Depetris, et al.. (2019). Improvement of Metastatic Colorectal Cancer Patient Survival: Single Institution Experience. Cancers. 11(3). 369–369. 3 indexed citations

16.

Lombardi, Pasquale, et al.. (2018). Emerging molecular target antagonists for the treatment of biliary tract cancer. Expert Opinion on Emerging Drugs. 23(1). 63–75. 14 indexed citations

17.

Filippi, Roberto, Pasquale Lombardi, Ilaria Depetris, et al.. (2018). Rationale for the use of metronomic chemotherapy in gastrointestinal cancer. Expert Opinion on Pharmacotherapy. 19(13). 1451–1463. 6 indexed citations

18.

Peraldo‐Neia, Caterina, Giuliana Cavalloni, Elisabetta Fenocchio, et al.. (2018). Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR. PLoS ONE. 13(1). e0191593–e0191593. 13 indexed citations

19.

Fenocchio, Elisabetta, Roberto Filippi, Ilaria Depetris, et al.. (2018). Improvement of metastatic colorectal cancer patient survival: Single institution experience. Annals of Oncology. 29. v72–v72. 1 indexed citations

20.

Fenocchio, Elisabetta, Ilaria Depetris, Delia Campanella, et al.. (2016). Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report. BMC Cancer. 16(1). 793–793. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact